Literature DB >> 8495233

Radioligand and functional estimates of the interaction of the 1,4-dihydropyridines, isradipine and lacidipine, with calcium channels in smooth muscle.

S Salomone1, T Godfraind.   

Abstract

1. The present experiments were undertaken in order to characterize further the apparently irreversible inhibition of the contraction of depolarized rat aorta caused by lacidipine, a 1,4-dihydropyridine calcium antagonist. 2. We studied the effect of lacidipine on contraction evoked by 100 mM KCl solution in rat aorta, treated by N omega-nitro-L-arginine (0.1 mM), an inhibitor of nitric oxide (NO) synthesis. We compared the effect of prolonged depolarization on lacidipine and (+)-isradipine inhibition and the reversal of this inhibition after washout in the absence of dihydropyridines. Assuming that the onset of lacidipine-evoked inhibition was a pseudo-first order association kinetics, we estimated the dissociation rate constant (k-1 = 0.031 min-1), the association rate constant (k1 = 2.70 x 10(8) M-1 min-1) and the dissociation constant (KD = k-1/k1 = 115 pM) which was close to the IC50 value in steady-state conditions (160 pM). 3. The inhibitory effects of lacidipine and (+)-isradipine on rat aorta contraction were reversibly enhanced after preincubation with the drug in a 40 mM KCl-solution. Washout with drug-free 40 mM K(+)-depolarizing solution reversed inhibition in the (+)-isradipine-treated preparations, but not in the lacidipine-treated ones. 4. Radioligand binding studies were performed with [3H]-lacidipine and [3H]-isradipine in microsomes from rat aorta and rat ileum. Both ligands bound to a homogeneous population of binding sites (for[3H]-lacidipine: KD = 23 +/- 2.6 pM, Bmax = 380 +/- 21 fmol mg-1 protein in membranes from aorta; KD =23 +/- 3.1 pM, Bmax = 790 +/- 60 fmol mg-1 protein in membranes from ileum; for [3H]-isradipine:KD = 140 +/- 46 pM, Bmax = 350 +/- 64 fmol mg-1 protein in membrane from aorta; KD = 68 +/- 14 pM,Bmax = 760 +/- 75 fmol mg-1 protein in membranes from ileum). After isotopic dilution, [3H]-lacidipine and [3H]-isradipine dissociated according to a monoexponential kinetics. In membranes from ileum, the calculated dissociation rate constants (kappa_ 1) were 0.0257 min-1 and 0.0595 min-1, for [3H]-lacidipine and[3H]-isradipine, respectively.5. The non specific binding of [3H]-lacidipine and [3H]-isradipine, was measured in intact rat aorta preparations incubated under the conditions of the functional experiments, in the presence of nifedipine(1 microM). After incubation with [3H]-lacidipine 77.6 +/- 1.9 pM for 2 h the concentration of drug in the tissue was 15.15 +/- 1.18 fmol mg-1 w.wt. and still amounted to 7.24 +/- 0.61 fmol mg-1 w.wt. after 3.5 h washout in drug-free solution. After incubation with [3H]-isradipine 47.2 +/- 0.4 pM for 2 h it was 2.26 +/-0.07 fmol mg-1 w.wt. and was undetectable after 3.5 h washout in a drug-free solution.6. It is concluded that lacidipine interacts reversibly with dihydropyridine binding sites and that the apparent irreversible inhibition of contraction in depolarized preparations could be related to a nonspecific binding in a tissue compartment different from the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8495233      PMCID: PMC2175600          DOI: 10.1111/j.1476-5381.1993.tb13537.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  26 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 2.  Calcium channels and calcium channel drugs: recent biochemical and biophysical findings.

Authors:  H Glossmann; D R Ferry; A Goll; J Striessnig; G Zernig
Journal:  Arzneimittelforschung       Date:  1985

3.  Kinetics of binding of membrane-active drugs to receptor sites. Diffusion-limited rates for a membrane bilayer approach of 1,4-dihydropyridine calcium channel antagonists to their active site.

Authors:  D G Rhodes; J G Sarmiento; L G Herbette
Journal:  Mol Pharmacol       Date:  1985-06       Impact factor: 4.436

4.  Calcium channels in muscle cells isolated from rat mesenteric arteries: modulation by dihydropyridine drugs.

Authors:  B P Bean; M Sturek; A Puga; K Hermsmeyer
Journal:  Circ Res       Date:  1986-08       Impact factor: 17.367

5.  Voltage-dependent block of calcium channel current in the calf cardiac Purkinje fiber by dihydropyridine calcium channel antagonists.

Authors:  M C Sanguinetti; R S Kass
Journal:  Circ Res       Date:  1984-09       Impact factor: 17.367

Review 6.  Quantitative analysis of drug-receptor interactions: I. Determination of kinetic and equilibrium properties.

Authors:  G A Weiland; P B Molinoff
Journal:  Life Sci       Date:  1981-07-27       Impact factor: 5.037

Review 7.  The classification of drugs and drug receptors in isolated tissues.

Authors:  T P Kenakin
Journal:  Pharmacol Rev       Date:  1984-09       Impact factor: 25.468

8.  Inhibition by prednisolon-bisguanylhydrazone of desensitization and of potassium loss produced by acetylcholine in intestinal smooth muscle.

Authors:  T Godfraind; J Burton
Journal:  Arch Int Pharmacodyn Ther       Date:  1967-03

9.  A calmodulin-stimulated Ca2+ pump in rat aorta plasma membranes.

Authors:  N Morel; M Wibo; T Godfraind
Journal:  Biochim Biophys Acta       Date:  1981-06-09

10.  Interactions of organic calcium channel antagonists with calcium channels in single frog atrial cells.

Authors:  A Uehara; J R Hume
Journal:  J Gen Physiol       Date:  1985-05       Impact factor: 4.086

View more
  6 in total

1.  Binding constants determined from Ca2+ current responses to rapid applications and washouts of nifedipine in frog cardiac myocytes.

Authors:  P F Méry; L Hove-Madsen; J L Mazet; R Hanf; R Fischmeister
Journal:  J Physiol       Date:  1996-07-01       Impact factor: 5.182

2.  Action of the calcium channel blocker lacidipine on cardiac hypertrophy and endothelin-1 gene expression in stroke-prone hypertensive rats.

Authors:  O Feron; S Salomone; T Godfraind
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

3.  Stereoselective effects of the enantiomers, quinidine and quinine, on depolarization- and agonist-mediated responses in rat isolated aorta.

Authors:  B F del Pozo; F Pérez-Vizcaíno; E Villamor; F Zaragozá; J Tamargo
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

Review 4.  Cardioselectivity of calcium antagonists.

Authors:  T Godfraind
Journal:  Cardiovasc Drugs Ther       Date:  1994-05       Impact factor: 3.727

5.  Voltage- and time-dependent inhibitory effects on rat aortic and porcine coronary artery contraction induced by propafenone and quinidine.

Authors:  F Pérez-Vizcaíno; B Fernández del Pozo; F Zaragozá; J Tamargo
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

Review 6.  Lacidipine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of hypertension.

Authors:  C R Lee; H M Bryson
Journal:  Drugs       Date:  1994-08       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.